Generic Arimidex is used for treating breast cancer in women who have been through menopause, including women with disease progression after tamoxifen therapy. More info »
Just wanted to write and say that I'm VERY satisfied with my purchase. I was
skeptical at first, the price seemed too good and the shipping process too
convoluted. But I sucked it up and took the plunge, ordered 90 of the lil blue guys
and sat back to wait for packages that might never come. Happily I was SO wrong! 9
days after my order was placed I received my first batch of 30+4, and just today
(another week later) I received the remaining 60. The quality of the product is
outstanding. If you\'re sitting there, wondering whether or not you should go ahead
and make a purchase here, quit wondering! The best prices, excellent service, and a
top-notch product are all present here. Go for it!
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth .
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - MarketWatch (press release)
NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayMarketWatch (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - MarketWatch (press release)
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality ReductionMarketWatch (press release)Drugs covered include: Abiraterone acetate (Zytiga), Afatinib (Tomtovok), Afimoxifene (TamoGel), Albumin-bound paclitaxel (Abraxane), Anastrozole (Arimidex), Apatinib, Bevacizumab (Avastin), Bosutinib, Capecitabine (Xeloda), Cediranib, .
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - EON: Enhanced Online News (press release)
NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayEON: Enhanced Online News (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .
Norton Rose Group | Pharma in brief - Canada: Federal Court of Appeal upholds ... - Linex Legal (press release) (registration)
Norton Rose Group | Pharma in brief - Canada: Federal Court of Appeal upholds .